Total Payments
$1,783
2024 Payments
$700.46
Companies
11
Transactions
58
Medicare Patients
7,473
Medicare Billing
$562,966
Payment Breakdown by Category
Food & Beverage$1,783 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,783 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $701.75 | 17 | $0 (2024) |
| Allergan, Inc. | $358.54 | 12 | $0 (2022) |
| Amgen Inc. | $263.30 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $155.12 | 8 | $0 (2024) |
| Biofrontera Inc. | $83.85 | 5 | $0 (2024) |
| PFIZER INC. | $51.19 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $46.15 | 2 | $0 (2022) |
| PruGen, Inc. Pharmaceuticals | $44.69 | 1 | $0 (2019) |
| Aclaris Therapeutics, Inc. | $35.26 | 2 | $0 (2019) |
| MERZ NORTH AMERICA, INC. | $26.08 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $700.46 | 16 | ABBVIE INC. ($512.09) |
| 2023 | $269.68 | 11 | ABBVIE INC. ($175.73) |
| 2022 | $410.35 | 15 | Allergan, Inc. ($274.64) |
| 2021 | $242.36 | 8 | Amgen Inc. ($129.71) |
| 2020 | $16.74 | 1 | Biofrontera Inc. ($16.74) |
| 2019 | $93.22 | 4 | PruGen, Inc. Pharmaceuticals ($44.69) |
| 2018 | $33.12 | 2 | Allergan Inc. ($21.42) |
| 2017 | $17.07 | 1 | Galderma Laboratories, L.P. ($17.07) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/11/2024 | ABBVIE INC. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $108.45 | General |
| Category: PLASTIC SURGERY | ||||||
| 08/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.81 | General |
| 06/18/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: ACNE | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Inflammation | ||||||
| 05/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $124.09 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $105.08 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.31 | General |
| 03/21/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $9.35 | General |
| Category: DERMATOLOGY | ||||||
| 03/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.29 | General |
| 03/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.29 | General |
| 12/12/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.69 | General |
| 12/05/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/01/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $89.96 | General |
| 10/30/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/08/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.53 | General |
| 06/21/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 05/16/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.07 | General |
| Category: DERMATOLOGY | ||||||
| 04/06/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,852 | 7,071 | $427,694 | $147,344 |
| 2022 | 18 | 1,691 | 7,501 | $374,022 | $123,193 |
| 2021 | 21 | 1,686 | 6,559 | $368,886 | $122,432 |
| 2020 | 23 | 2,244 | 8,128 | $508,539 | $169,997 |
Total Patients
7,473
Total Services
29,259
Medicare Billing
$562,966
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 463 | 745 | $129,196 | $44,381 | 34.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 199 | 227 | $49,176 | $16,637 | 33.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 204 | 249 | $48,277 | $16,346 | 33.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 270 | 393 | $50,495 | $13,683 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 126 | 181 | $19,591 | $7,265 | 37.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 42 | 62 | $21,210 | $6,986 | 32.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 196 | 1,207 | $15,398 | $5,992 | 38.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 95 | 149 | $14,335 | $5,591 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 78 | 78 | $16,763 | $5,441 | 32.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 33 | 35 | $13,837 | $5,023 | 36.3% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 17 | 3,600 | $5,884 | $4,542 | 77.2% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 16 | 17 | $9,041 | $3,164 | 35.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 21 | 23 | $7,433 | $2,831 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 24 | $5,889 | $2,344 | 39.8% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 17 | $6,298 | $2,290 | 36.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $6,149 | $2,153 | 35.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 13 | $3,131 | $1,104 | 35.3% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 19 | $3,514 | $900.65 | 25.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,077 | $668.53 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 372 | 541 | $95,530 | $31,628 | 33.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 180 | 223 | $48,913 | $16,534 | 33.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 187 | 223 | $44,301 | $13,723 | 31.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 255 | 360 | $46,915 | $12,215 | 26.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 156 | 214 | $23,450 | $8,080 | 34.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 41 | 49 | $17,016 | $6,233 | 36.6% |
About Dr. Renee Glover, MD
Dr. Renee Glover, MD is a Specialist healthcare provider based in Nags Head, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699779124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renee Glover, MD has received a total of $1,783 in payments from pharmaceutical and medical device companies, with $700.46 received in 2024. These payments were reported across 58 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,783).
As a Medicare-enrolled provider, Glover has provided services to 7,473 Medicare beneficiaries, totaling 29,259 services with total Medicare billing of $562,966. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Nags Head, NC
- Active Since 06/13/2005
- Last Updated 11/01/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1699779124
Products in Payments
- BOTOX (Biological) $564.38
- Otezla (Drug) $241.85
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $108.45
- AMELUZ (Drug) $83.85
- EUCRISA (Drug) $51.19
- COSENTYX (Biological) $46.15
- Xeomin (Biological) $26.08
- RHOFADE (Drug) $23.56
- Enbrel (Biological) $21.45
- AKLIEF (Drug) $19.39
- ARAZLO (Drug) $17.07
- Humira (Biological) $13.93
- ESKATA (Drug) $11.70
- BOTOX COSMETIC (Biological) $11.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.